Phathom Pharmaceuticals (PHAT) Leases (2022 - 2025)
Historic Leases for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $2.7 million.
- Phathom Pharmaceuticals' Leases rose 22340.94% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 22340.94%. This contributed to the annual value of $613000.0 for FY2024, which is 5844.07% down from last year.
- Phathom Pharmaceuticals' Leases amounted to $2.7 million in Q3 2025, which was up 22340.94% from $873000.0 recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Leases registered a high of $2.7 million during Q3 2025, and its lowest value of $388000.0 during Q1 2025.
- For the 4-year period, Phathom Pharmaceuticals' Leases averaged around $1.6 million, with its median value being $1.7 million (2023).
- The largest annual percentage gain for Phathom Pharmaceuticals' Leases in the last 5 years was 22340.94% (2025), contrasted with its biggest fall of 6930.38% (2025).
- Quarter analysis of 4 years shows Phathom Pharmaceuticals' Leases stood at $2.3 million in 2022, then plummeted by 35.51% to $1.5 million in 2023, then tumbled by 58.44% to $613000.0 in 2024, then soared by 339.48% to $2.7 million in 2025.
- Its Leases was $2.7 million in Q3 2025, compared to $873000.0 in Q2 2025 and $388000.0 in Q1 2025.